Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
Steenbruggen, T. G., Bouwer, N. I., Smorenburg, C. H., Rier, H. N., Jager, A., Beelen, K., ten Tije, A. J., de Jong, P. C., Drooger, J. C., Holterhues, C., Kitzen, J. J. E. M., Levin, M. -D., Sonke, G. S.
Published in Breast cancer research and treatment (01.12.2019)
Published in Breast cancer research and treatment (01.12.2019)
Get full text
Journal Article
H. Wijfjes, G. Voerman (eds.), Mediatization of Politics in History
K. Beelen
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Get full text
Journal Article
CYP2C192 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment
Beelen, K., Opdam, M., Severson, T. M., Koornstra, R. H. T., Vincent, A. D., Hauptmann, M., van Schaik, R. H. N., Berns, E. M. J. J., Vermorken, J. B., van Diest, P. J., Linn, S. C.
Published in Breast cancer research and treatment (01.06.2013)
Published in Breast cancer research and treatment (01.06.2013)
Get full text
Journal Article
St. Gallen endocrine response classes predict recurrence rates over time
Koornstra, R.H.T, Beelen, K.J, Vincent, A.D, van der Noort, V, van Diest, P.J, Linn, S.C
Published in Breast (Edinburgh) (01.12.2015)
Published in Breast (Edinburgh) (01.12.2015)
Get full text
Journal Article
1405 POSTER DISCUSSION Cyp2C192 Polymorphism Predicts Benefit of Adjuvant Tamoxifen in ER Positive Postmenopausal Breast Cancer Patients
Beelen, K, Koornstra, R, Opdam, M, Severson, T, Vincent, A, van Diest, R.J, Linn, S
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer
Berns, Katrien, Horlings, Hugo M., Hennessy, Bryan T., Madiredjo, Mandy, Hijmans, E. Marielle, Beelen, Karin, Linn, Sabine C., Gonzalez-Angulo, Ana Maria, Stemke-Hale, Katherine, Hauptmann, Michael, Beijersbergen, Roderick L., Mills, Gordon B., van de Vijver, Marc J., Bernards, René
Published in Cancer cell (01.10.2007)
Published in Cancer cell (01.10.2007)
Get full text
Journal Article
Abstract PD4-12: Clustering of activated proteins of the PI3K and MAPK pathways distinguishes ER+/HER2- primary breast cancer patients with preferential tamoxifen benefit
Kruger, DT, Beelen, K, Opdam, M, Sanders, J, van der Noort, V, Boven, E, Linn, SC
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
LBA18 POSEIDON randomized phase II trial: Tamoxifen (TAM) + taselisib or placebo (PLA) in patients (pts) with hormone receptor positive (HR+)/HER2- metastatic breast cancer (MBC)
Oliveira, M., Baird, R.D., Voorthuis, R.A.B., De Boo, L., van Rossum, A.G.J., Garrigos Cubells, L., Muñoz, S., López-García, D., Saura Manich, C., Schrier, M., Mandjes, I., Sikorska, K., Schot, M., Kateb, A., Mather, C., Beelen, K., Cortés, J., Caldas, C., Linn, S.C.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
H. Wijfjes, G. Voerman (eds.), Mediatization of Politics in History
K. Beelen
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Get full text
Journal Article
H. Wijfjes, G. Voerman (eds.), Mediatization of Politics in History
K. Beelen
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Get full text
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Journal Article
H. Wijfjes, G. Voerman (eds.), Mediatization of Politics in History
K. Beelen
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Get full text
Published in Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden (01.01.2011)
Journal Article
Abstract OT2-01-11: Phase II of POSEIDON: A phase Ib / randomized phase II trial of tamoxifen plus taselisib or placebo in hormone receptor positive, HER2 negative, metastatic breast cancer patients with prior exposure to endocrine treatment
Oliveira, M, Baird, RD, van Rossum, AGJ, Beelen, K, Garcia-Corbacho, J, Mandjes, IAM, Vallier, AL, van Werkhoven, E, Garrigós, L, Kumar, S, van Tinteren, H, Muñoz, S, Linossi, C, Rosing, H, Miquel, JM, Schrier, M, de Vries Schultink, A, Saura, C, Gallagher, WM, Bernards, R, Tabernero, J, Cortés, J, Caldas, C, Linn, SC
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
“TRIASUS”: A Web Based Information Management System for Sharing Pre- And Post-Transplantation Clinical, HLA and Chimaerism Data
Sterkenburg, M.J, Boelens, J.J, Beelen, K, Verdonck, L, Lie, J, Otten, H, Rozemuller, E.H, Tilanus, M.G.J
Published in Biology of blood and marrow transplantation (01.02.2009)
Published in Biology of blood and marrow transplantation (01.02.2009)
Get full text
Journal Article
Are St. Gallen endocrine response classes predictive for recurrence rates over time?
Koornstra, R. H., Beelen, K. J., Vincent, A., van Diest, P. J., Linn, S. C.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment
Beelen, K, Opdam, M, Severson, T M, Koornstra, R H T, Vincent, A D, Hauptmann, M, van Schaik, R H N, Berns, E M J J, Vermorken, J B, van Diest, P J, Linn, S C
Published in Breast cancer research and treatment (01.06.2013)
Published in Breast cancer research and treatment (01.06.2013)
Get full text
Journal Article
Abstract P6-17-19: What to do with trastuzumab therapy after achieving radiological complete remission (rCR) in HER2+ metastatic breast cancer (MBC)?
Steenbruggen, TG, Bouwer, NI, Smorenburg, CH, Rier, HN, Jager, A, Beelen, KJ, ten Tije, AJ, de Jong, PC, Drooger, JC, Holterhues, C, Horlings, HM, Sanders, J, Levin, M-D, Sonke, GS
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract PD01-02: Increased expression of phosporylated mTOR in metastatic breast tumors compared to primary tumors in patients who received adjuvant endocrine therapy
Hoefnagel, LDC, Beelen, KJ, Opdam, M, Vincent, A, Linn, SC, van Diest, PJ
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Abstract PD01-03: Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Beelen, KJ, Opdam, M, Severson, TM, Koornstra, RHT, Vincent, A, Wesseling, J, Muris, JJ, Berns, EMJJ, Vermorken, JB, van Diest, PJ, Linn, SC
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article